Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma

doi:10.3748/wjg.v25.i22.2776

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5490)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

336

WORD

272

HTML

3180

Figures (1-6)

220

Sum=4008

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

625

Download

857

Sum=1482

Jun 14, 2019 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jun 14, 2019; 25(22): 2776-2787
Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2776

Full Size Figure Download Figure

Figure 2 STC2 was hypermethylated in colon cancer tissues and the high expression of STC2 indicated poor prognosis. A: Comparison of the promoter methylation level of STC2 in 37 cases normal colon and 313 cases tumor tissues; B: The cumulative survival rate was conducted between high and low expression of STC2. ^cP < 0.001 vs normal. STC2: Stanniocalcin 2.

Citation: Li JB, Liu ZX, Zhang R, Ma SP, Lin T, Li YX, Yang SH, Zhang WC, Wang YP. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma. World J Gastroenterol 2019; 25(22): 2776-2787
URL: https://www.wjgnet.com/1007-9327/full/v25/i22/2776.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i22.2776